Relationship between electronic structure and cytotoxic activity of azulenes

In Vivo

Volumn 20, Issue 3, 2006, Pages 385-390

  Kurihara, Teruo ^a   Noguchi, Mayumi ^a   Noguchi, Takashi ^a   Wakabayashi, Hidetsugu ^a   Motohashi, Noboru ^b   Sakagami, Hiroshi ^c  

^a JOSAI UNIVERSITY   (Japan)

^b MEIJI PHARMACEUTICAL UNIVERSITY   (Japan)

^c MEIKAI UNIVERSITY SCHOOL OF DENTISTRY   (Japan)

Author keywords

Azulenes; Cytotoxic activity; Dipole moment ( ); PM3 calculation method

Indexed keywords

1,3 DIBROMOAZULENE; AZULENE; AZULENE DERIVATIVE; CYTOTOXIC AGENT; METHYL 7 ISOPROPYL 2 METHOXYAZULENE 1 CARBOXYLIC ACID; UNCLASSIFIED DRUG;

ARTICLE; CELL LINE; CYTOTOXICITY; DIPOLE; DRUG DESIGN; DRUG STRUCTURE; HALOGENATION; HUMAN; HUMAN CELL; HYDROPHOBICITY; PARTITION COEFFICIENT; PHASE TRANSITION; QUANTITATIVE STRUCTURE ACTIVITY RELATION; STRUCTURE ACTIVITY RELATION;

EID: 33646839905     PISSN: 0258851X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (13)

1. Nozoe T and Asao T: Azulenes and heptafulvenes. In: Dai-Yuki Kagaku. Kotake M (ed.). Asakura-Shoten. Tokyo (in Japanese). Vol. 13, pp. 439-534, 1960.
2. Nozoe T, Breslow R, Hafner K, Ito S and Murata I (eds.): Topics in Nonbenzenoid Aromatic Chemistry. Hirokawa Publ Co., Tokyo, Vol. I, pp. 1-295, 1973.
3. Nozoe T, Breslow R, Hafner K, Ito S and Murata I (eds.): Topics in Nonbenzenoid Aromatic Chemistry. Hirokawa Publ Co. Tokyo (in Japanese). Vol. II, pp. 1-379, 1977.
4. Zeller KP: Methoden der oranischen chemie. Houben-Weyl, Band V/2c, pp. 127-418, 1985.
5. Frigola J, Pares J, Corbera J, Vano D, Merce R, Torrens A, Mas J and Valenti E: 7-Azetidinylquinolones as antibacterial agents. Synthesis and structure-activity relationship. J Med Chem 36: 801-810, 1993.
6. Wakabayashi S, Sekiguchi H, Kosakai K, Mochizuki S, Kashima M and Tomiyama A: General pharmacological properties of an anti-ulcer drug, azuletil sodium (KT1-21) (in Japanese). Folia Pharmacol Japan 96: 185-204, 1990.
7. 2-(2-pyridyl methyl)-5-isopropyl-3,8-dimethylazulene-1-carboxamidine (HNS-32) in pig coronary artery. Pharm Pharmacol Commun 6: 397-404, 2000.
8. Tomiyama T, Yokota M, Wakabayashi S, Kosakai K and Yanagisawa T: Design, synthesis, and pharmacology of 3-substituted sodium azulene-1-sulfonates and related compounds: non-prostanoid thromboxane A2 receptor antagonists. J Med Chem 36: 791-800, 1993.
9. Doukas PH, Speaker TJ and Thompson RS: Azulene analogs of pharmacological agents III. Acute toxicity and local anesthetic activity of azulylamides and azulenecarboxamides. J Pharm Sci 64: 158-161, 1975.
10. Wakabayashi H, Hashiba K, Yokoyama K, Hashimoto K, Kikuchi H, Nishikawa H, Kurihara T, Satoh K, Shioda S, Saito S, Kusano S, Nakashima H, Motohashi N and Sakagami H: Cytotoxic activity of azulenes against human oral tumor cell lines. Anticancer Res 23: 4747-4756, 2003.
11. PM3 semi-emprical MO calculations were performed by MOPAC version 6 on an Intellistation M Pro personal computer.
12. Ohkura K and Hori H: Analysis of structure-permeability correlation of nitrophenol analogs in newborn rat abdominal skin using semi empirical molecular orbital calculation. Bioorg Med Chem 7: 309-314, 1998.
13. Kurihara T, Yamada T, Yamamoto A, Kawase M, Motohashi N, Sakagami H and Molnar J: Relationship between electronic structure and cytotoxic activity of dopamine and 3-benzazepine derivatives. In Vivo 18: 443-448, 2004.